Skip to main content
CVSACovista Inc.Buy Wait6.3·$126.50
CVSA · Why this verdict

Why Covista (CVSA) is rated BUY WAIT

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictBUY WAIT
Overall score6.3/10
ConfidenceMEDIUM
MacroRISK_OFF
TrendMatrix Research · core thesis

Engine thesis — one sentence

Covista screens attractively valued at a forward P/E of 13.2 times and a PEG of 0.88, underpinned by four consecutive earnings beats averaging more than 11% above consensus; the chief offset is negative price momentum that has not cleared the minimum threshold, keeping the entry setup cautious despite sound fundamentals.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Price momentum has stalled well below the acceptable threshold, with falling on-balance volume indicating distribution rather than accumulation — a near-term headwind that limits the attractiveness of the current entry even as fundamentals remain intact.

↓Deteriorating
Warnings
Expectation
Over 12 months the stock recovers toward its near-term price target as momentum improves, validating that the weakness was temporary.

CounterThe stock remains above its 200-day moving average, meaning the weakness may be a pullback within a longer uptrend rather than a structural reversal.

At a forward P/E of 13.2 times and a PEG of 0.88, the stock screens as attractively valued, offering a meaningful margin of safety and potential for multiple expansion if earnings momentum continues.

→Stable
Valuation breakdown
Expectation
Forward P/E holds at or below 15 times as earnings grow into the valuation, and the stock outperforms sector peers on a 12-month total-return basis.

CounterWeak organic growth limits the catalyst for re-rating; inexpensive stocks with minimal top-line momentum can remain cheap for extended periods.

A Piotroski F-Score of 7 out of 9 combined with strong free-cash-flow quality signals a financially healthy business with limited near-term distress risk.

→Stable
Quality breakdown
Expectation
The Piotroski F-Score remains at 7 or above for four consecutive quarters and free-cash-flow quality does not deteriorate materially.

CounterA mid-range moat score means financial strength has not translated into durable pricing power; the quality profile is solid but not exceptional.

The company has beaten consensus EPS estimates in each of the last four reported quarters, with average upside of roughly 11% above expectations — a pattern consistent with management consistently under-promising and over-delivering.

↓Deteriorating
Earnings
Expectation
Average quarterly EPS surprise remains above 5% and the beat streak extends to six or more consecutive quarters over the next 12 months.

CounterRevenue growth is near the bottom of the peer range, suggesting beats reflect modest consensus targets on a slow-growth business rather than genuine earnings acceleration.

Per-dimension breakdown

Value

7.3/10data confidence 100%
ComponentSub-score
P/E7.5
P/S8.8
EV/EBITDA5.4
Fwd P/E8.8
PEG7.3
Analyst target6.0
  • ▸Forward P/E: 12.6x
  • ▸PEG: 0.95
  • ▸Attractively valued

Quality

7.0/10data confidence 100%
ComponentSub-score
ROE6.2
ROA5.6
Gross margin7.5
Op margin7.7
Net margin6.4
Current ratio4.3
FCF quality9.3
Moat7.0
Piotroski F8.9
  • ▸Excellent cash conversion: 129% FCF/NI
  • ▸Strong Piotroski F-Score: 8/9

Growth

7.5/10data confidence 67%
ComponentSub-score
Rev growth4.9
EPS growth10.0

Momentum

5.0/10data confidence 100%
ComponentSub-score
RSI7.5
MACD7.9
OBV1.0
MA position4.0
Volume4.6
  • ▸Uptrend pullback (RSI 40) - buy opportunity
  • ▸Volume distribution (falling OBV)
  • ▸Above 200-day MA

Sentiment

6.6/10data confidence 100%
ComponentSub-score
LLM sentiment7.0
Analyst rating5.0
Price target8.2
  • ▸LLM news sentiment: +0.40 (n=1)
  • ▸Analyst upside: 25%

Insider

4.8/10data confidence 100%
ComponentSub-score
materiality4.5
insider conviction2.0
holder change5.8
notable moves7.0
  • ▸Modest insider selling — $2,704,097 (0.063% of mkt cap)

Peer rank

4.8/10data confidence 80%
ComponentSub-score
value rank3.2
quality rank5.8
growth rank6.7

Technical

6.5/10data confidence 100%
ComponentSub-score
bollinger6.9
support resistance6.4
52w position6.2

Risk (lower is worse)

4.6/10data confidence 100%
ComponentSub-score
short interest4.3
days to cover2.2
volatility5.0
put call3.0
implied vol1.6
beta9.1
debt equity7.2
  • ▸Elevated put/call: 1.54
  • ▸High IV: 70%

Catalyst

6.4/10data confidence 100%
ComponentSub-score
erm3.5
earnings history10.0
earnings timing5.0
surprise avg8.4
news activity5.0
  • ▸Perfect beat streak: 4Q
  • ▸Earnings today

How the verdict was assembled

Engine trigger

Earnings today. Wait until post-earnings.

Engine technical detail
verdict_path: L3:NEWS_BLOCK|ENTRY_STICKY:WITHIN_BAND
Passed (5)
  • MOMENTUM:5.0>=4.5
  • INSIDER:OK
  • NEWS_EVENTS:NONE_RECENT
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
  • ASYMMETRY:1.1<1.5@spot
  • EARNINGS_PROXIMITY:0d<=7d
Warning (2)
  • MOMENTUM:5.0<5.5 (soft — BUY_NOW allowed but watch)
  • 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
1.11
Upside
+6.7%
Downside
6.0%
Sizing output
STARTER

Setup— — No clear chart pattern; technical signals are mixed

EdgeNo clear edge — No clear edge identified

SuitabilityAggressive — MCap $4.3B<$5B

Investment implication

A recent news event triggered an L3 news-block on the verdict path. Trigger: Earnings today. Wait until post-earnings. The 10-dimension scores remain Growth at 7.5 (strongest), but ASYMMETRY:1.1<1.5@spot also fails — the news block is the proximate trigger, not the sole driver.

The strongest dimensions are Growth at 7.5, Value at 7.3, and Quality at 7.0; the weakest are Risk (lower is worse) at 4.6, Peer rank at 4.8, and Insider at 4.8. The V9 engine flagged 2 failed gates with 2 warnings, producing an asymmetric reward-to-risk of 1.11 and an engine sizing output of STARTER.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Consistent Earnings Beat Streak

    Trip ifEPS surprise falls below 0% for 2 consecutive quarters.

  • P2Attractive Forward Valuation Low Peg

    Trip ifForward P/E expands above 20x from the current 13.2x for 2 consecutive quarters.

  • P3Solid Piotroski Financial Health

    Trip ifPiotroski F-Score falls below 5 out of 9 in any single quarter.

  • P4Negative Momentum Near Term Headwind

    Trip ifPrice closes above $132.81 (near-term price target) and holds for 2 consecutive weeks, confirming the momentum headwind has resolved.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home › Stocks › CVSA › Why this verdict